Product
TTRNA-DCs
1 clinical trial
2 indications
Indication
MedulloblastomaIndication
Neuroectodermal TumorClinical trial
Recurrent Medulloblastoma and Primitive Neuroectodermal Tumor Adoptive T Cell Therapy During Recover From Myeloablative Chemotherapy and Hematopoietic Stem Cell TransplantationStatus: Active (not recruiting), Estimated PCD: 2020-03-28